|93.32||+0.2700||+0.29%||Vol 1.83M||1Y Perf 39.30%|
|Aug 8th, 2022 16:03 DELAYED|
|- -||-1.07 -1.15%|
|Target Price||100.31||Analyst Rating||Strong Buy 1.43|
|Potential %||7.49||Finscreener Ranking||★★ 44.87|
|Insiders Trans % 3/6/12 mo.||-100/-25/-80||Value Ranking||★ 40.14|
|Insiders Value % 3/6/12 mo.||-100/-17/-82||Growth Ranking||★★+ 48.70|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-16/-83||Income Ranking||— -|
|Price Range Ratio 52W %||96.39||Earnings Rating||Strong Buy|
|Market Cap||54.13B||Earnings Date||26th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.69|
|EPS Growth Next 5 Years %||13.70|
|Avg. Weekly Volume||2.31M|
|Avg. Monthly Volume||2.77M|
|Avg. Quarterly Volume||2.71M|
Centene Corporation (NYSE: CNC) stock closed at 93.32 per share at the end of the most recent trading day (a 0.29% change compared to the prior day closing price) with a volume of 1.83M shares and market capitalization of 54.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 71300 people. Centene Corporation CEO is Michael F. Neidorff.
The one-year performance of Centene Corporation stock is 39.3%, while year-to-date (YTD) performance is 13.25%. CNC stock has a five-year performance of 125.6%. Its 52-week range is between 59.67 and 94.58, which gives CNC stock a 52-week price range ratio of 96.39%
Centene Corporation currently has a PE ratio of 35.60, a price-to-book (PB) ratio of 1.93, a price-to-sale (PS) ratio of 0.51, a price to cashflow ratio of 10.00, a PEG ratio of 2.32, a ROA of 2.01%, a ROC of 4.19% and a ROE of 5.75%. The company’s profit margin is 1.95%, its EBITDA margin is 3.10%, and its revenue ttm is $102.16 Billion , which makes it $174.66 revenue per share.
Of the last four earnings reports from Centene Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $1.69 for the next earnings report. Centene Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Centene Corporation is Strong Buy (1.43), with a target price of $100.31, which is +7.49% compared to the current price. The earnings rating for Centene Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Centene Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Centene Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 7.50, ATR14 : 2.19, CCI20 : 71.32, Chaikin Money Flow : 0.14, MACD : 2.13, Money Flow Index : 66.22, ROC : 3.21, RSI : 72.12, STOCH (14,3) : 76.71, STOCH RSI : 0.63, UO : 56.61, Williams %R : -23.29), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Centene Corporation in the last 12-months were: Brent D. Layton (Sold 4 000 shares of value $282 524 ), Brent Layton (Sold 8 000 shares of value $565 048 ), Christopher A. Koster (Sold 28 600 shares of value $2 006 862 ), Christopher J. Coughlin (Buy at a value of $976 440), Colin A. Toney (Sold 2 807 shares of value $232 813 ), Colin Toney (Sold 2 807 shares of value $232 813 ), David P. Thomas (Sold 4 000 shares of value $310 440 ), H. James Dallas (Buy at a value of $250 564), Katie Casso (Sold 8 000 shares of value $633 520 ), Katie N. Casso (Sold 8 000 shares of value $633 520 ), Kenneth A. Burdick (Sold 180 790 shares of value $13 425 000 ), Lori J. Robinson (Sold 1 200 shares of value $111 324 ), Mark J. Brooks (Sold 14 760 shares of value $1 109 250 ), Michael F. Neidorff (Sold 90 000 shares of value $6 789 120 ), Orlando Ayala (Sold 8 430 shares of value $591 533 ), Richard A. Gephardt (Sold 41 520 shares of value $3 144 089 ), Shannon Bagley (Sold 17 000 shares of value $1 477 810 ), Theodore R. Samuels (Buy at a value of $507 494)
Wed, 27 Jul 2022 12:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Replimune Group (REPL)- TipRanks. All rights reserved.
Wed, 22 Jun 2022 03:55 GMT Centene (CNC) Receives a Hold from Mizuho Securities- TipRanks. All rights reserved.
Thu, 28 Apr 2022 03:56 GMT Centene (CNC) Gets a Hold Rating from Mizuho Securities- TipRanks. All rights reserved.
Wed, 27 Apr 2022 16:37 GMT Centene (CNC) Receives a Buy from Morgan Stanley- TipRanks. All rights reserved.
Wed, 27 Apr 2022 04:55 GMT Centene (CNC) Receives a Buy from Deutsche Bank- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.